Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide and infection: another view

G Schoedon1, M Schneemann, R Walter

  • 1Department of Medicine, University of Zürich Medical School, Switzerland.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|October 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

European guidelines on diagnosis and treatment of phenylketonuria: First revision.

Molecular genetics and metabolism·2025
Same author

'Ripple' effect on infant zBMI trajectory of an internet-based weight loss program for low-income postpartum women.

Pediatric obesity·2018
Same author

Diet changes alter paternally inherited epigenetic pattern in male Wild guinea pigs.

Environmental epigenetics·2018
Same author

Homocarnosinosis: A historical update and findings in the SPG11 gene.

Acta neurologica Scandinavica·2018
Same author

The complete European guidelines on phenylketonuria: diagnosis and treatment.

Orphanet journal of rare diseases·2017
Same author

The challenges of managing coexistent disorders with phenylketonuria: 30 cases.

Molecular genetics and metabolism·2015
Same journal

Understanding the Clone-Censor-Weight Method in Observational Studies of Antibiotic Duration.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Treatment of Progressive Multifocal Leukoencephalopathy with Third-Party Allogeneic BK Virus T Cells.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Protection Against Recurrent Typhoid Fever Conferred by a Prior Episode: Evidence from a Large Cohort Study in Dhaka, Bangladesh.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Pre-treatment Gut Microbiome Diversity and Function Linked to Cytotoxic and Natural Killer Cell Immune Responses after N-803 Treatment in People with HIV.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Reconsidering ambiguous language in infectious disease consult recommendations.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
Same journal

Antibiotic Treatment Duration for Uncomplicated Monomicrobial Enterococcal Bloodstream Infection: A Multicenter Target Trial Emulation.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles

Nitric oxide (NO) has dual roles, but in humans, it unlikely mediates inflammatory vasodilation or acts as an antimicrobial. Human NO synthesis is compartmentalized, preventing toxicity during inflammation.

Area of Science:

  • Clinical Infectious Diseases
  • Physiology
  • Immunology

Background:

  • Nitric oxide (NO) exhibits both toxic and signaling properties, earning nicknames like "murderer" and "mediator."
  • Understanding NO's role in inflammation, sepsis, and as an antimicrobial system is crucial for clinical infectious disease specialists.
  • Existing reviews often overlook critical species differences in NO synthesis and function.

Purpose of the Study:

  • To review the dual aspects of nitric oxide (NO) synthesis.
  • To evaluate NO's potential as an endothelium-derived relaxing factor (EDRF) in human inflammation and sepsis.
  • To assess NO's potential as an antimicrobial system in humans.

Main Methods:

  • Literature review focusing on NO synthesis, EDRF function, and antimicrobial properties.

Related Experiment Videos

  • Comparative analysis of NO synthesis across different animal species.
  • Clinical perspective integrating findings relevant to infectious diseases.

    • Main Results:

    • Significant species differences exist in NO synthesis and its physiological effects.
    • NO is unlikely to function as an EDRF mediating inflammatory vasodilation in humans.
    • NO synthesized by human phagocytes likely lacks a significant antimicrobial function.

    Conclusions:

    • Human NO synthesis is more confined and compartmentalized than in other species.
    • This compartmentalization in humans helps avoid detrimental effects like toxicity and unwanted vasodilation during inflammation.
    • NO's primary roles in humans may be distinct from those observed in certain animal models, particularly in inflammatory contexts.